Last week, CDC estimates found the variant accounted for at least 26 percent of all U.S. infections.
The CDC currently lists the B.1.1.7 variant as a “variant of concern,” and believes it is about 50 percent more transmissible than other previously dominant coronavirus strains. The variant is also likely to have an increased disease severity based on hospitalizations and case fatality rates.
The U.S. has reported 16,275 cases of this variant as of April 6, with Florida (3,192) and Michigan (1,649) recording the highest number of B.1.1.7 cases.
After months of progress, COVID-19 cases are rising in most states, with many experts pointing to the rapid spread of variants. Ultimately, COVID-19 vaccines are effective, but the variants underscore a renewed need for caution right now.
More articles on public health:
Atlantic Health System rapid COVID-19 test can detect 3 variants
States ranked by percentage of population vaccinated
Variants stalling pandemic progress in US: 8 notes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
